Related Experiment Video
Updated: Nov 26, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Receptor mimicking TGF-β1 binding peptide for targeting TGF-β1 signaling
David G Belair1, Jae Sung Lee2, Anna V Kellner3
1Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, USA. wlmurphy@wisc.edu.
New peptides bind transforming growth factor-β1 (TGF-β1) to reduce scar formation and fibrosis. These TGF-β1 binding peptides offer potential treatments for fibrotic diseases and tissue repair.
Area of Science:
- Biochemistry
- Biomaterials Science
- Regenerative Medicine
Background:
- Prolonged transforming growth factor-β1 (TGF-β1) signaling contributes to scar formation and fibrosis in multiple organs.
- Current treatments for fibrotic diseases and tissue repair have limitations.
Purpose of the Study:
- To develop novel TGF-β1 binding peptides that inhibit TGF-β1 activity.
- To engineer these peptides for conjugation to biomaterials for therapeutic applications.
Main Methods:
- Identified TGF-β1 binding peptides from TGF-β receptor domains.
- Engineered peptide sequences using molecular docking simulations.
- Evaluated peptide binding and biological activity in vitro and in cell-based assays.
Main Results:
- Developed a TGF-β1 binding peptide, RIPΔ, derived from the TGF-β type I receptor.
- RIPΔ demonstrated sequence-specific binding to TGF-β1.
- RIPΔ reduced TGF-β1 biological activity in both soluble and biomaterial-conjugated forms.
Conclusions:
- Engineered peptides can effectively inhibit TGF-β1 signaling.
- This approach shows promise for treating fibrotic diseases and promoting soft tissue repair.
- Biomimetic design of peptide inhibitors offers a new strategy for therapeutic development.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Receptor Tyrosine Kinases
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...